Key result
Childhood body mass index and LDL cholesterol exhibited moderate temporal tracking over 15 years (R2=35.7% and 32.5%), resulting in low detection rates for predicting high adult risk.
Why the study?
Excess adiposity and circulating lipoprotein lipids in childhood predict adult cardiometabolic disease, but the statistical feasibility of primordial prediction and prevention using temporal tracking remained to be evaluated.
Does individualized biomarker screening in childhood accurately predict high cardiometabolic risk in adulthood?
Cohort (n=12,212)
Yes
Does individualized biomarker screening in childhood accurately predict high cardiometabolic risk in adulthood?
Effect estimate: R2(15) = 35.7% for BMI
Individualized biomarker screening in childhood has low statistical feasibility for predicting adult high-risk status, suggesting broad population-based primordial prevention is more useful.
Childhood adiposity and lipid tracking may enable primordial prevention; leaves open whether early intervention alters adult cardiometabolic risk.
CONTEXT AND OBJECTIVE: Excess adiposity and circulating lipoprotein lipids in childhood are predictive of cardiometabolic disease in adulthood. We analysed temporal tracking for body mass and lipid biomarkers using population-based time-series to assess the statistical feasibility of primordial prediction and prevention. DESIGN AND PARTICIPANTS: Individuals born between 1962-1992 were included from four European local community cohorts. Serial measurements of weight, height, waist and lipoprotein lipids were analysed for 12,212 participants (ages 5-49 years, follow-ups 15-31 years depending on cohort). Longitudinal tracking was quantified by autocorrelation R2 over the same individuals between any two visits in the series; the weakening of R2(Δt) with increasing follow-up time was modelled by exponential decay. RESULTS: Based on the decay model, we calculated autocorrelation for two surveys fifteen years apart as a simplified tracking indicator: R2(15) = 35.7% for body-mass index, R2(15) = 28.1% for waist-height ratio and R2(15) = 32.5% for low-density lipoprotein (LDL) cholesterol. Total and high-density lipoprotein cholesterol were comparable to LDL cholesterol. Triglycerides exhibited weak tracking. The detection rate (DR5) at 5% false positive rate (FPR) of children who were in the top risk decile as adults was DR5(15) = 38.9% for body mass index and DR5(15) = 30.9% for LDL cholesterol. CONCLUSIONS: Individualised biomarker screening at low FPR misclassifies the majority of children who will have high values as adults (low statistical feasibility). Biomarker tracking is more useful for guiding broad population-based primordial prevention programmes that can be extended to all children at risk without harm from false positives.
No takes yet. Share an insight, caveat, or question.
Mäkinen et al. (2026) conducted a cohort in Cardiometabolic risk (n=12,212). Childhood body mass and lipid biomarkers was evaluated on Longitudinal tracking quantified by autocorrelation R2 over 15 years (R2(15) = 35.7% for BMI). Childhood body mass index and LDL cholesterol exhibited moderate temporal tracking over 15 years (R2=35.7% and 32.5%), resulting in low detection rates for predicting high adult risk.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: